<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Wilhelm, A.D.* et al. Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients. Breast Cancer Res. 27:107 (2025)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=74981&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=74981&amp;la=de</guid>
      <pubDate>Fri, 11 Jul 2025 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Tollot-Wegner, M.* et al. TRPS1 maintains luminal progenitors in the mammary gland by repressing SRF/MRTF activity. Breast Cancer Res. 26:74 (2024)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=70623&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=70623&amp;la=de</guid>
      <pubDate>Tue, 21 May 2024 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Morra, A.* et al. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Res. 23:86 (2021)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64440&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64440&amp;la=de</guid>
      <pubDate>Mon, 28 Feb 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Sanz-Moreno, A. et al. RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer. Breast Cancer Res. 23:42 (2021)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61808&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=61808&amp;la=de</guid>
      <pubDate>Wed, 26 May 2021 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Penkert, J.* et al. Breast cancer patients suggestive of Li-Fraumeni syndrome: Mutational spectrum, candidate genes, and unexplained heredity. Breast Cancer Res. 20:87 (2018)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54102&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54102&amp;la=de</guid>
      <pubDate>Thu, 06 Sep 2018 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Quante, A.S. ; Whittemore, A.S.* ; Shriver, T.* ; Strauch, K. &amp; Terry, M.B.* Breast cancer risk assessment across the risk continuum: Genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res. 14:R144 (2012)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11859&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11859&amp;la=de</guid>
      <pubDate>Mon, 31 Dec 2012 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>